Breaking News

Catalent Expands Patient-Centric Dose Form Mfg. Capabilities

$40 million investment at Winchester site adds spray drying, stick pack and expanded capabilities in controlled-release tableting and encapsulation

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent has unveiled plans to invest up to $40 million at its manufacturing facility in Winchester, KY. The investment will see the installation of new equipment that will increase the site’s formulation and controlled-release tablet and capsule manufacturing capabilities, and capacity.   New technologies that are included in the investment include a laser drill for osmotic drug delivery, stick pack dosage manufacturing capabilities, and roller compaction and fluid bed capacity will be increase...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters